新星測量儀器 NVMI 深 滬
已收盤 05-08 16:00:00 美东时间
521.16
+16.620
+3.29%
華盛通- 最 高521.84
- 今 開515.34
- 成交量 39.17万股
- 最 低 511.19
- 昨 收 504.54
- 總市值 165.64亿
- 52周最高 550.00
- 市盈率 靜 65.50
- 換手率 1.23%
- 52周最低 179.00
- 委 比 -93.18%
- 總股本 3178.30万
- 歷史最高 550.00
- 量 比 1.22
- 振 幅 2.11%
- 歷史最低 5.11
- 每 手 1
- 風險率 95.22%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Concentra revises 2026 guidance to $2.275B-$2.375B revenue and $460M-$480M adjusted EBITDA
Earnings Call Insights: Concentra Group Holdings Parent, Inc. (CON) Q1 2026 Management view CEO William Newton said the company had “a strong start to the year,” reporting “Total company revenue was $...
05-09 06:42
Nova Leap Health reports Q1 results
Nova Leap Health press release (NLH:CA): Q1 net income of $324,587. Revenues of $7.85M More on Nova Leap Health Nova Leap Health reports Q4 results Historical earnings data for Nova Leap Health Financ...
05-09 01:44
Alpha Buying: Insider Conviction in High-Risk Biotech
Insider buying matters in every industry, but it carries a special weight in bi...
05-08 00:04
Jazz, AstraZeneca, Astellas: Foreign Healthcare's strongest Quant picks
Foreign healthcare stocks are earning some of the market's strongest Quant conviction right now, with the top five names on this ranking all carrying scores above 4.19, a cluster of high-conviction si...
05-07 19:50
Baird Maintains Outperform on LivaNova, Lowers Price Target to $76
Baird analyst David Rescott maintains LivaNova (NASDAQ:LIVN) with a Outperform and lowers the price target from $78 to $76.
05-07 19:41
Earnings Scheduled For May 6, 2026
Companies Reporting Before The Bell • Deluxe (NYSE:DLX) is expected to report q...
05-07 05:03
Davita, Bloomin' Brands, Compass And Other Big Stocks Moving Higher On Wednesday
Dow Jones up 500 points, DaVita Inc (DVA) shares rise after better-than-expected earnings and raised guidance. Other gaining stocks include EVC, BLMN, MNKD, FLEX, HUT, AVTX, COMP, VCYT, and SSRM.
05-06 22:39
Novavax Q1 2026 Earnings Call Transcript
Novavax (NASDAQ:NVAX) released first-quarter financial results and hosted an ea...
05-06 21:54
LivaNova Raises FY2026 Sales Guidance from $1.431B-$1.445B to $1.445B-$1.458B vs $1.494B Est
Full-Year 2026 GuidanceLivaNova now expects full-year 2026 revenue to grow between 7.0% and 8.0% (versus 6.0% and 7.0% prior) on a constant-currency basis. Foreign currency is expected to be a tailwind of approximately
05-06 18:19
LivaNova Raises FY2026 Adj EPS Guidance from $4.15-$4.25 to $4.20-$4.30 vs $4.21 Est;
Full-Year 2026 GuidanceLivaNova now expects full-year 2026 revenue to grow between 7.0% and 8.0% (versus 6.0% and 7.0% prior) on a constant-currency basis. Foreign currency is expected to be a tailwind of approximately
05-06 18:06
